A database containing qualitative information on the genotoxic activity of about 3000 chemicals is described. The initial aim for the construction of the database was to develop an instumnt for comparing the performance of different genotodcity assay systems. One appLication of the database is the prediction of expeced results in any go idt assay for chemicals that were tested in a small number of genotoccity assays. ITe Bayesian p n is alculated based on the sensitivities and specifdties betweenany redtivetest and thebtget test for which the dionis to be determined. The predictivity of the system for in vivo m malian assays is at present (with the exception of the micronucleus assay and the in vio sister chromatid exchanges) l d, in priulr because ofthe lmited number ofchemicals tested in the expensive in Wivo assays and, in addition, due to the lack ofsufficient information on negative compounds. A continued updating of the database will possibly help to overcome some of the present difficulties.
Introduction
The aim ofgenetic toxicology is to detect those chemical com 4 for weak positive will be considered.
CASRNs and the names ofthe chemicals are contained in one file; CASRNs and assay results are in another file. Table 1 gives the list ofthe major groups ofgenotoxicity assays and genetic end points included in the database.
The data contained in the database have been predominantly taken from the following sources: Gene-Tox reports, publications of the U.S. National Toxicology Program (NTP) (in particular the results of Drosophila assays), International Collaborative Studies, some reviews, and the database published by Palajda and Rosenkranz (1 (3) .
PREDICTING ASSAY RESULTS. Theoretically, the information contained in the database can be used to calculate predictions for the outcome ofany genotoxicity assay for any chemical for which minimal information on its genotoxic potential is available, e.g., for which at least one genotoxicity assay has been performed. As more experimental information is available, the precision ofthe predictions improves.
Definitions. Tests are all the assays (with their individual genetic end points) contained in the database. The target test is the particular genetic end point ofan assay for which the prediction is to be calculated.
Method. The predictions are calculated by applying the Bayes' theorem to the sensitivities and specificities calculated for any pair ofassays available in the database. Sensitivity describes what fraction of chemical found positive in the target assay was also positive in the predictive assay. Specificity describes what fraction of chemicals negative in the target test was also negative in the predictive assay. The Bayesian analysis is described in detail by Pet-Edwards et al. (4, 5 predictions have not yet been possible. The reasons for this are a) that a relatively small number of chemicals tested in these assays are contained in the database, b) these chemicals have not been systematically tested in the STT, and c) the number of chemicals reported negative in an in vivo assay is limited, thus the calculation of reliable sensitivities and specificities becomes the major problem.
Because the database is predominantly based on the Gene-Tox reports, we expect that an update of the database with the data published after the completion of the Gene-Tox phase 1 might lead to some improvements ofthe system to study predictions for the in vivo assays other than carcinogenicity.
